Prescient Therapeutics Limited (PTX.AX)
AUD 0.05
(4.26%)
AUD 0.05
(4.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -7.18 Million AUD | 27.31% |
| 2023 | -9.88 Million AUD | -39.25% |
| 2022 | -7.09 Million AUD | -30.81% |
| 2021 | -5.42 Million AUD | -20.76% |
| 2020 | -4.49 Million AUD | 18.95% |
| 2019 | -5.54 Million AUD | -53.77% |
| 2018 | -3.6 Million AUD | 4.17% |
| 2017 | -3.76 Million AUD | -115.38% |
| 2016 | -1.74 Million AUD | 16.01% |
| 2015 | -2.08 Million AUD | -59.11% |
| 2014 | -1.3 Million AUD | -187.28% |
| 2013 | -455.08 Thousand AUD | 76.88% |
| 2012 | -1.96 Million AUD | 5.1% |
| 2011 | -2.07 Million AUD | 1.16% |
| 2010 | -2.09 Million AUD | -22.99% |
| 2009 | -1.7 Million AUD | 27.26% |
| 2008 | -2.34 Million AUD | 50.84% |
| 2007 | -4.77 Million AUD | 0.27% |
| 2006 | -4.78 Million AUD | 14.61% |
| 2005 | -5.6 Million AUD | -35.41% |
| 2004 | -4.13 Million AUD | -23.04% |
| 2003 | -3.36 Million AUD | -5.58% |
| 2002 | -3.18 Million AUD | -6.01% |
| 2001 | -3 Million AUD | -24.4% |
| 2000 | -2.41 Million AUD | 15.23% |
| 1999 | -2.84 Million AUD | -176.32% |
| 1998 | -1.03 Million AUD | 21.1% |
| 1997 | -1.3 Million AUD | -1432.82% |
| 1996 | 98.08 Thousand AUD | 476.95% |
| 1995 | 17 Thousand AUD | 101.41% |
| 1994 | -1.2 Million AUD | -1182.98% |
| 1993 | -94 Thousand AUD | -202.17% |
| 1992 | 92 Thousand AUD | -54.46% |
| 1991 | 202 Thousand AUD | -71.55% |
| 1990 | 710 Thousand AUD | 498.88% |
| 1989 | -178 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -10.89 Million AUD | -10.24% |
| 2024 Q4 | -3.2 Million AUD | 0.0% |
| 2024 Q2 | -5.92 Million AUD | 0.0% |
| 2023 Q2 | -4.27 Million AUD | 0.0% |
| 2023 FY | -9.88 Million AUD | -39.25% |
| 2023 Q4 | -5.61 Million AUD | 0.0% |
| 2022 FY | -7.09 Million AUD | -30.81% |
| 2022 Q4 | -3.6 Million AUD | 0.0% |
| 2022 Q2 | -3.49 Million AUD | 0.0% |
| 2021 Q4 | -2.97 Million AUD | 0.0% |
| 2021 FY | -5.42 Million AUD | -20.76% |
| 2021 Q2 | -2.45 Million AUD | 0.0% |
| 2020 Q4 | -2.16 Million AUD | 0.0% |
| 2020 FY | -4.49 Million AUD | 18.95% |
| 2020 Q2 | -2.33 Million AUD | 0.0% |
| 2019 FY | -5.54 Million AUD | -53.77% |
| 2019 Q4 | -3.18 Million AUD | 0.0% |
| 2019 Q2 | -1.64 Million AUD | 0.0% |
| 2018 Q2 | -1.15 Million AUD | 0.0% |
| 2018 Q4 | -1.51 Million AUD | 0.0% |
| 2018 FY | -3.6 Million AUD | 4.17% |
| 2017 Q4 | -1.49 Million AUD | 0.0% |
| 2017 FY | -3.76 Million AUD | -115.38% |
| 2017 Q2 | -1.04 Million AUD | 0.0% |
| 2016 Q4 | -1.07 Million AUD | 0.0% |
| 2016 Q2 | -669.52 Thousand AUD | 0.0% |
| 2016 FY | -1.74 Million AUD | 16.01% |
| 2015 Q4 | -1.02 Million AUD | 0.0% |
| 2015 FY | -2.08 Million AUD | -59.11% |
| 2015 Q2 | -1.05 Million AUD | 0.0% |
| 2014 Q4 | -548.49 Thousand AUD | 0.0% |
| 2014 Q2 | -758.85 Thousand AUD | 0.0% |
| 2014 FY | -1.3 Million AUD | -187.28% |
| 2013 Q4 | 17.52 Thousand AUD | 115.46% |
| 2013 Q3 | -113.28 Thousand AUD | 75.0% |
| 2013 FY | -455.08 Thousand AUD | 76.88% |
| 2013 Q2 | -453.15 Thousand AUD | 7.92% |
| 2013 Q1 | -492.14 Thousand AUD | 0.0% |
| 2012 Q1 | -518.59 Thousand AUD | 0.0% |
| 2012 FY | -1.96 Million AUD | 5.1% |
| 2012 Q4 | -492.14 Thousand AUD | 0.0% |
| 2012 Q3 | -492.14 Thousand AUD | 0.0% |
| 2012 Q2 | -492.14 Thousand AUD | 5.1% |
| 2011 Q4 | -518.59 Thousand AUD | 0.0% |
| 2011 Q3 | -518.59 Thousand AUD | 0.0% |
| 2011 Q2 | -518.59 Thousand AUD | 1.16% |
| 2011 Q1 | -524.66 Thousand AUD | 0.0% |
| 2011 FY | -2.07 Million AUD | 1.16% |
| 2010 Q1 | -426.6 Thousand AUD | 0.0% |
| 2010 Q4 | -524.66 Thousand AUD | 0.0% |
| 2010 FY | -2.09 Million AUD | -22.99% |
| 2010 Q3 | -524.66 Thousand AUD | 0.0% |
| 2010 Q2 | -524.66 Thousand AUD | -22.99% |
| 2009 Q2 | -426.6 Thousand AUD | 27.26% |
| 2009 Q4 | -426.6 Thousand AUD | 0.0% |
| 2009 Q1 | -586.48 Thousand AUD | 0.0% |
| 2009 FY | -1.7 Million AUD | 27.26% |
| 2009 Q3 | -426.6 Thousand AUD | 0.0% |
| 2008 Q4 | -586.48 Thousand AUD | 0.0% |
| 2008 Q1 | -1.19 Million AUD | 0.0% |
| 2008 FY | -2.34 Million AUD | 50.84% |
| 2008 Q2 | -586.48 Thousand AUD | 50.84% |
| 2008 Q3 | -586.48 Thousand AUD | 0.0% |
| 2007 Q1 | -1.19 Million AUD | 0.0% |
| 2007 Q3 | -1.19 Million AUD | 0.0% |
| 2007 FY | -4.77 Million AUD | 0.27% |
| 2007 Q4 | -1.19 Million AUD | 0.0% |
| 2007 Q2 | -1.19 Million AUD | 0.27% |
| 2006 FY | -4.78 Million AUD | 14.61% |
| 2006 Q2 | -1.19 Million AUD | 14.61% |
| 2006 Q3 | -1.19 Million AUD | 0.0% |
| 2006 Q1 | -1.4 Million AUD | 0.0% |
| 2006 Q4 | -1.19 Million AUD | 0.0% |
| 2005 FY | -5.6 Million AUD | -35.41% |
| 2005 Q1 | -1.03 Million AUD | 0.0% |
| 2005 Q4 | -1.4 Million AUD | 0.0% |
| 2005 Q3 | -1.4 Million AUD | 0.0% |
| 2005 Q2 | -1.4 Million AUD | -35.41% |
| 2004 Q3 | -1.03 Million AUD | 0.0% |
| 2004 Q2 | -1.03 Million AUD | -23.04% |
| 2004 FY | -4.13 Million AUD | -23.04% |
| 2004 Q1 | -840.94 Thousand AUD | 0.0% |
| 2004 Q4 | -1.03 Million AUD | 0.0% |
| 2003 FY | -3.36 Million AUD | -5.58% |
| 2003 Q3 | -840.94 Thousand AUD | 0.0% |
| 2003 Q4 | -840.94 Thousand AUD | 0.0% |
| 2003 Q2 | -840.94 Thousand AUD | -5.58% |
| 2003 Q1 | -796.52 Thousand AUD | 0.0% |
| 2002 Q2 | -796.52 Thousand AUD | -6.01% |
| 2002 Q3 | -796.52 Thousand AUD | 0.0% |
| 2002 Q4 | -796.52 Thousand AUD | 0.0% |
| 2002 FY | -3.18 Million AUD | -6.01% |
| 2002 Q1 | -751.37 Thousand AUD | 0.0% |
| 2001 Q2 | -751.37 Thousand AUD | 34.11% |
| 2001 FY | -3 Million AUD | -24.4% |
| 2001 Q4 | -751.37 Thousand AUD | 0.0% |
| 2001 Q1 | -1.14 Million AUD | 0.0% |
| 2001 Q3 | -751.37 Thousand AUD | 0.0% |
| 2000 Q3 | -1.14 Million AUD | 0.0% |
| 2000 FY | -2.41 Million AUD | 15.23% |
| 2000 Q1 | -712.49 Thousand AUD | 0.0% |
| 2000 Q2 | -1.14 Million AUD | -60.06% |
| 2000 Q4 | -1.14 Million AUD | 0.0% |
| 1999 FY | -2.84 Million AUD | -176.32% |
| 1999 Q1 | -257.85 Thousand AUD | 0.0% |
| 1999 Q2 | -712.49 Thousand AUD | -176.32% |
| 1999 Q4 | -712.49 Thousand AUD | 0.0% |
| 1999 Q3 | -712.49 Thousand AUD | 0.0% |
| 1998 FY | -1.03 Million AUD | 21.1% |
| 1998 Q4 | -257.85 Thousand AUD | 0.0% |
| 1998 Q3 | -257.85 Thousand AUD | 0.0% |
| 1998 Q2 | -257.85 Thousand AUD | 21.1% |
| 1998 Q1 | -326.81 Thousand AUD | 0.0% |
| 1997 Q2 | -326.81 Thousand AUD | -1432.85% |
| 1997 FY | -1.3 Million AUD | -1432.82% |
| 1997 Q3 | -326.81 Thousand AUD | 0.0% |
| 1997 Q1 | 24.52 Thousand AUD | 0.0% |
| 1997 Q4 | -326.81 Thousand AUD | 0.0% |
| 1996 FY | 98.08 Thousand AUD | 476.95% |
| 1996 Q4 | 24.52 Thousand AUD | 0.0% |
| 1996 Q3 | 24.52 Thousand AUD | 0.0% |
| 1996 Q2 | 24.52 Thousand AUD | 476.94% |
| 1996 Q1 | 4250.00 AUD | 0.0% |
| 1995 FY | 17 Thousand AUD | 101.41% |
| 1995 Q4 | 4250.00 AUD | 0.0% |
| 1995 Q3 | 4250.00 AUD | 0.0% |
| 1995 Q2 | 4250.00 AUD | 101.41% |
| 1995 Q1 | -301.5 Thousand AUD | 0.0% |
| 1994 Q1 | -23.5 Thousand AUD | 0.0% |
| 1994 FY | -1.2 Million AUD | -1182.98% |
| 1994 Q4 | -301.5 Thousand AUD | 0.0% |
| 1994 Q3 | -301.5 Thousand AUD | 0.0% |
| 1994 Q2 | -301.5 Thousand AUD | -1182.98% |
| 1993 Q3 | -23.5 Thousand AUD | 0.0% |
| 1993 Q2 | -23.5 Thousand AUD | -232.39% |
| 1993 Q1 | 17.75 Thousand AUD | 0.0% |
| 1993 Q4 | -23.5 Thousand AUD | 0.0% |
| 1993 FY | -94 Thousand AUD | -202.17% |
| 1992 Q3 | 17.75 Thousand AUD | 0.0% |
| 1992 Q4 | 17.75 Thousand AUD | 0.0% |
| 1992 FY | 92 Thousand AUD | -54.46% |
| 1992 Q1 | -4500.00 AUD | 0.0% |
| 1992 Q2 | 17.75 Thousand AUD | 494.44% |
| 1991 Q4 | -4500.00 AUD | 0.0% |
| 1991 Q3 | -4500.00 AUD | 0.0% |
| 1991 FY | 202 Thousand AUD | -71.55% |
| 1991 Q2 | -4500.00 AUD | -101.98% |
| 1991 Q1 | 227.5 Thousand AUD | 0.0% |
| 1990 Q2 | 227.5 Thousand AUD | 437.04% |
| 1990 Q4 | 227.5 Thousand AUD | 0.0% |
| 1990 Q3 | 227.5 Thousand AUD | 0.0% |
| 1990 Q1 | -67.5 Thousand AUD | 0.0% |
| 1990 FY | 710 Thousand AUD | 498.88% |
| 1989 Q3 | -67.5 Thousand AUD | 0.0% |
| 1989 FY | -178 Thousand AUD | 0.0% |
| 1989 Q4 | -67.5 Thousand AUD | 0.0% |
| 1989 Q2 | -67.5 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | -36.583% |
| Acrux Limited | -9.83 Million AUD | 26.923% |
| Actinogen Medical Limited | -12.83 Million AUD | 44.027% |
| AnteoTech Limited | -11.72 Million AUD | 38.717% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -26.718% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 0.092% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -392.515% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 63.338% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -62.406% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -56.595% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -134.661% |
| Biome Australia Limited | -1.91 Million AUD | -275.615% |
| Biotron Limited | -5.15 Million AUD | -39.51% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 51.112% |
| BTC Health Limited | 1.05 Million AUD | 780.992% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 41.62% |
| CSL Limited | 5.64 Billion AUD | 100.127% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 83.959% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 114.622% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 18.41% |
| Dimerix Limited | -25.05 Million AUD | 71.323% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 173.96% |
| Hexima Limited | -1 Million AUD | -612.408% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -150.068% |
| Immuron Limited | -5.8 Million AUD | -23.88% |
| Immutep Limited | -44.93 Million AUD | 84.008% |
| Imugene Limited | -140.93 Million AUD | 94.901% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -236.817% |
| Memphasys Limited | -2.7 Million AUD | -165.77% |
| Nanollose Limited | -1.24 Million AUD | -474.994% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 103.18% |
| Noxopharm Limited | -7.53 Million AUD | 4.626% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -249.439% |
| Nyrada Inc. | -4.56 Million AUD | -57.585% |
| Orthocell Limited | -11.68 Million AUD | 38.478% |
| PharmAust Limited | -6.65 Million AUD | -7.926% |
| Patrys Limited | -3.53 Million AUD | -103.055% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 88.963% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 0.624% |
| PYC Therapeutics Limited | -38.85 Million AUD | 81.506% |
| Race Oncology Limited | -13.38 Million AUD | 46.292% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 84.778% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 67.41% |
| Starpharma Holdings Limited | -15.15 Million AUD | 52.593% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | -47.385% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -21.02% |